PACS Group Financials
This page shows PACS Group (PACS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
PACS Group has an operating margin of 3.0%, meaning the company retains $3 of operating profit per $100 of revenue. This below-average margin results in a low score of 15/100, suggesting thin profitability after operating expenses. This is down from 6.7% the prior year.
PACS Group's revenue surged 31.4% year-over-year to $4.1B, reflecting rapid business expansion. This strong growth earns a score of 100/100.
PACS Group carries a low D/E ratio of 0.35, meaning only $0.35 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 98/100, indicating a strong balance sheet with room for future borrowing.
PACS Group's current ratio of 0.96 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 18/100, which could limit financial flexibility.
PACS Group's ROE of 7.9% shows moderate profitability relative to equity, earning a score of 31/100. This is down from 117.4% the prior year.
PACS Group scores 1.69, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
PACS Group passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, PACS Group generates $6.59 in operating cash flow ($367.3M OCF vs $55.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
PACS Group earns $2.8 in operating income for every $1 of interest expense ($123.1M vs $44.3M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
PACS Group generated $4.1B in revenue in fiscal year 2024. This represents an increase of 31.4% from the prior year.
PACS Group reported $55.8M in net income in fiscal year 2024. This represents a decrease of 50.6% from the prior year.
PACS Group earned $0.38 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 56.8% from the prior year.
PACS Group held $157.7M in cash against $251.0M in long-term debt as of fiscal year 2024.
PACS Group paid $0.22 per share in dividends in fiscal year 2024. This represents a decrease of 65.2% from the prior year.
PACS Group had 155M shares outstanding in fiscal year 2024. This represents an increase of 20.6% from the prior year.
PACS Group's gross margin was 19.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 1.9 percentage points from the prior year.
PACS Group's operating margin was 3.0% in fiscal year 2024, reflecting core business profitability. This is down 3.7 percentage points from the prior year.
PACS Group's net profit margin was 1.4% in fiscal year 2024, showing the share of revenue converted to profit. This is down 2.3 percentage points from the prior year.
PACS Group's ROE was 7.9% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 109.6 percentage points from the prior year.
PACS Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B+2.7% | $1.3B+2.5% | $1.3B+5.7% | $1.2B+29.1% | $935.7M+1.7% | $919.8M+7.8% | $853.2M+8.1% | $789.2M |
| Cost of Revenue | $1.0B+2.5% | $1.0B-0.3% | $1.0B+7.8% | $949.4M+24.6% | $762.1M+3.6% | $736.0M+8.3% | $679.6M+6.4% | $638.5M |
| Gross Profit | $298.3M+3.4% | $288.4M+13.8% | $253.4M-2.0% | $258.5M+49.0% | $173.6M-5.6% | $183.8M+5.9% | $173.6M+15.2% | $150.7M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $102.5M+2.2% | $100.3M+1.6% | $98.7M+10.1% | $89.6M-34.4% | $136.7M+191.4% | $46.9M+11.8% | $42.0M-15.3% | $49.6M |
| Operating Income | $86.3M+7.2% | $80.5M+67.2% | $48.1M-33.1% | $72.0M+293.6% | -$37.2M-156.9% | $65.3M+4.4% | $62.5M+71.8% | $36.4M |
| Interest Expense | $8.5M+95.9% | $4.4M-36.9% | $6.9M-25.8% | $9.3M-6.2% | $9.9M-38.4% | $16.1M | N/A | $10.2M |
| Income Tax | $24.0M-13.3% | $27.6M+92.7% | $14.3M-42.6% | $25.0M+230.8% | -$19.1M-183.6% | $22.9M+51.6% | $15.1M+102.1% | $7.5M |
| Net Income | $52.4M+2.8% | $51.0M+79.0% | $28.5M-23.5% | $37.2M+216.7% | -$31.9M-191.6% | $34.8M+2.0% | $34.1M+71.3% | $19.9M |
| EPS (Diluted) | $0.32+3.2% | $0.31+82.4% | $0.17-22.7% | $0.22+204.8% | $-0.21-177.8% | $0.27-3.6% | $0.28+86.7% | $0.15 |
PACS Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.6B+2.3% | $5.5B+0.1% | $5.5B+4.8% | $5.2B+33.3% | $3.9B+1.9% | $3.9B+9.9% | $3.5B | N/A |
| Current Assets | $1.1B+4.6% | $1.1B-0.4% | $1.1B+15.3% | $938.3M+22.9% | $763.7M-7.0% | $820.8M+13.7% | $722.1M | N/A |
| Cash & Equivalents | $355.7M+20.9% | $294.2M+2.3% | $287.5M+82.3% | $157.7M+114.9% | $73.4M-9.7% | $81.2M+10.6% | $73.4M+6.3% | $69.1M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $628.3M-1.5% | $638.1M-6.3% | $680.7M+6.1% | $641.8M+10.6% | $580.1M-5.2% | $611.8M+11.7% | $547.8M | N/A |
| Goodwill | N/A | N/A | N/A | $60.8M | N/A | N/A | $59.0M | N/A |
| Total Liabilities | $4.7B+1.3% | $4.7B-1.0% | $4.7B+4.7% | $4.5B+33.6% | $3.4B-9.4% | $3.7B+9.7% | $3.4B | N/A |
| Current Liabilities | $1.2B+2.6% | $1.2B+5.4% | $1.1B+13.2% | $978.4M+100.4% | $488.2M-8.8% | $535.4M+17.2% | $456.9M | N/A |
| Long-Term Debt | $245.9M-0.4% | $247.0M-0.8% | $249.1M-0.8% | $251.0M+10.5% | $227.1M-1.6% | $230.9M+18.0% | $195.7M | N/A |
| Total Equity | $871.3M+8.0% | $806.8M+7.5% | $750.2M+5.7% | $709.6M+32.2% | $536.8M+372.3% | $113.7M+18.3% | $96.1M+21.7% | $79.0M |
| Retained Earnings | $249.9M+26.5% | $197.5M+34.8% | $146.5M+24.1% | $118.0M+81.0% | $65.2M-42.5% | $113.3M+18.1% | $96.0M | N/A |
PACS Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $204.8M+289.5% | $52.6M-65.0% | $150.2M+132.6% | $64.6M+85.8% | $34.8M-40.8% | $58.8M+705.6% | -$9.7M-163.9% | $15.2M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$97.1M-199.5% | -$32.4M-97.4% | -$16.4M+84.3% | -$104.3M+13.7% | -$121.0M-1.9% | -$118.7M-98.0% | -$59.9M-31.5% | -$45.6M |
| Financing Cash Flow | -$46.3M-252.8% | -$13.1M-223.1% | -$4.1M-102.9% | $138.6M+95.8% | $70.8M+105.2% | $34.5M-64.9% | $98.2M+145.3% | $40.0M |
| Dividends Paid | $0 | $0 | $0 | $0-100.0% | $16.2M-7.0% | $17.5M+53.3% | $11.4M-54.9% | $25.3M |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
PACS Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 22.2%+0.2pp | 22.0%+2.2pp | 19.8%-1.6pp | 21.4%+2.8pp | 18.6%-1.4pp | 20.0%-0.4pp | 20.3%+1.3pp | 19.1% |
| Operating Margin | 6.4%+0.3pp | 6.2%+2.4pp | 3.8%-2.2pp | 6.0%+9.9pp | -4.0%-11.1pp | 7.1%-0.2pp | 7.3%+2.7pp | 4.6% |
| Net Margin | 3.9%+0.0pp | 3.9%+1.7pp | 2.2%-0.9pp | 3.1%+6.5pp | -3.4%-7.2pp | 3.8%-0.2pp | 4.0%+1.5pp | 2.5% |
| Return on Equity | 6.0%-0.3pp | 6.3%+2.5pp | 3.8%-1.4pp | 5.2% | N/A | 30.6%-4.9pp | 35.5%+10.3pp | 25.2% |
| Return on Assets | 0.9%0.0pp | 0.9%+0.4pp | 0.5%-0.2pp | 0.7%+1.5pp | -0.8%-1.7pp | 0.9%-0.1pp | 1.0% | N/A |
| Current Ratio | 0.94+0.0 | 0.92-0.1 | 0.98+0.0 | 0.96-0.6 | 1.56+0.0 | 1.53-0.0 | 1.58 | N/A |
| Debt-to-Equity | 0.28-0.0 | 0.31-0.0 | 0.33-0.0 | 0.35-0.1 | 0.42-1.6 | 2.030.0 | 2.04 | N/A |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: The current ratio is below 1.0 (0.96), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is PACS Group's annual revenue?
PACS Group (PACS) reported $4.1B in total revenue for fiscal year 2024. This represents a 31.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is PACS Group's revenue growing?
PACS Group (PACS) revenue grew by 31.4% year-over-year, from $3.1B to $4.1B in fiscal year 2024.
Is PACS Group profitable?
Yes, PACS Group (PACS) reported a net income of $55.8M in fiscal year 2024, with a net profit margin of 1.4%.
What is PACS Group's earnings per share (EPS)?
PACS Group (PACS) reported diluted earnings per share of $0.38 for fiscal year 2024. This represents a -56.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
How much debt does PACS Group have?
As of fiscal year 2024, PACS Group (PACS) had $157.7M in cash and equivalents against $251.0M in long-term debt.
What is PACS Group's gross margin?
PACS Group (PACS) had a gross margin of 19.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is PACS Group's operating margin?
PACS Group (PACS) had an operating margin of 3.0% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is PACS Group's net profit margin?
PACS Group (PACS) had a net profit margin of 1.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
Does PACS Group pay dividends?
Yes, PACS Group (PACS) paid $0.22 per share in dividends during fiscal year 2024.
What is PACS Group's return on equity (ROE)?
PACS Group (PACS) has a return on equity of 7.9% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is PACS Group's operating cash flow?
PACS Group (PACS) generated $367.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are PACS Group's total assets?
PACS Group (PACS) had $5.2B in total assets as of fiscal year 2024, including both current and long-term assets.
How many shares does PACS Group have outstanding?
PACS Group (PACS) had 155M shares outstanding as of fiscal year 2024.
What is PACS Group's current ratio?
PACS Group (PACS) had a current ratio of 0.96 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is PACS Group's debt-to-equity ratio?
PACS Group (PACS) had a debt-to-equity ratio of 0.35 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is PACS Group's return on assets (ROA)?
PACS Group (PACS) had a return on assets of 1.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is PACS Group's Altman Z-Score?
PACS Group (PACS) has an Altman Z-Score of 1.69, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is PACS Group's Piotroski F-Score?
PACS Group (PACS) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are PACS Group's earnings high quality?
PACS Group (PACS) has an earnings quality ratio of 6.59x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can PACS Group cover its interest payments?
PACS Group (PACS) has an interest coverage ratio of 2.8x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is PACS Group?
PACS Group (PACS) scores 53 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.